|
|
E P Jenkins, S Andersson, J Imperato-McGinley, J D Wilson, D W Russell
J Clin Invest. 1992;
89(1):293
doi:10.1172/JCI115574
Abstract |
Full text
| PDF
T
he enzyme steroid 5 alpha-reductase catalyzes the conversion of testosterone into the more potent androgen, dihydrotestosterone, and impairment of this reaction causes a form of male pseudohermaphroditism in which genetic males differentiate predominantly as phenotypic females. We previously isolated cDNA clones that encode a human steroid 5 alpha-reductase enzyme. Here, we report molecular and genetic studies demonstrating that the gene encoding this cDNA is normal in subjects with the genetic disease steroid 5 alpha-reductase deficiency. We further show that in contrast to the major steroid 5 alpha-reductase in the prostate and cultured skin fibroblasts, the cDNA-encoded enzyme exhibits a neutral to basic pH optima and is much less sensitive to inhibition by the 4-aza steroid, finasteride (MK-906). The results provide genetic, biochemical, and pharmacological support for the existence of at least two steroid 5 alpha-reductase isozymes in man.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(140)
| Title and authors |
Publication |
Year |
Estrogen and androgen signaling in the pathogenesis of BPH
Clement K. M. Ho, Fouad K. Habib
|
Nat Rev Urol
|
2011 |
Synthesis and bioactivity of new Finasteride conjugate
Zhao Shuang, Wu Jiazhen, Yang Lijuan, Li Zhuo, Yu Dahai, Li Jinfeng, Yu Jing, Liang Yongtao, Wang En-si, Fang Xuexun
|
Bioorganic & Medicinal Chemistry Letters
|
2011 |
The Critical Role of Androgens in Prostate Development
Jean D. Wilson
|
Endocrinology & Metabolism Clinics of North America
|
2011 |
Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
Abdulmaged M. Traish, John Hassani, Andre T. Guay, Michael Zitzmann, Michael L. Hansen
|
The Journal of Sexual Medicine
|
2011 |
On the effects of a plant extract of Orthosiphon stamineus on sebum-related skin imperfections
B. Vogelgesang, N. Abdul-Malak, C. Reymermier, C. Altobelli, J. Saget
|
Int J Cosmet Sci
|
2011 |
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)
J. Curtis Nickel, Peter Gilling, Teuvo L. Tammela, Betsy Morrill, Timothy H. Wilson, Roger S. Rittmaster
|
BJU International
|
2011 |
Molecular biology of androgen insensitivity
Jarmo Jääskeläinen
|
Molecular and Cellular Endocrinology
|
2011 |
New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
Yazmín Arellano, Eugene Bratoeff, Mariana Garrido, Juan Soriano, Yvonne Heuze, Marisa Cabeza
|
Steroids
|
2011 |
Rook's Textbook of Dermatology
A. G. Messenger, D. A. R. de Berker, R. D. Sinclair
|
Rook's Textbook of Dermatology
|
2010 |
Biology and natural history of prostate cancer and the role of chemoprevention
M. T. Rosenberg, M. Froehner, D. Albala, M. M. Miner
|
International Journal of Clinical Practice
|
2010 |
|